Joel R Garbow Selected Research

Joel R Garbow Research Topics

Disease

34	Neoplasms (Cancer) 07/2023 - 01/2002
14	Necrosis 07/2023 - 10/2009
7	Glioma (Gliomas) 12/2021 - 02/2007
6	Status Epilepticus (Complex Partial Status Epilepticus) 03/2024 - 01/2017
6	Brain Injuries (Brain Injury) 03/2024 - 01/2017
6	Brain Neoplasms (Brain Tumor) 10/2022 - 07/2013
6	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 07/2013
6	Hypoxia (Hypoxemia) 01/2020 - 01/2015
4	Neuroinflammatory Diseases 03/2024 - 01/2017
4	Seizures (Absence Seizure) 03/2024 - 01/2017
4	Optic Nerve Glioma 12/2021 - 05/2007
4	Inflammation (Inflammations) 01/2020 - 06/2011
4	Cognitive Dysfunction 01/2019 - 01/2016
3	Hemorrhage 01/2021 - 05/2014
3	Neoplasm Metastasis (Metastasis) 01/2018 - 12/2004
3	Breast Neoplasms (Breast Cancer) 01/2018 - 12/2004
2	Atrophy 03/2024 - 01/2017
2	Intellectual Disability (Idiocy) 11/2023 - 02/2023
2	Autistic Disorder (Autism) 11/2023 - 02/2023
2	Edema (Dropsy) 10/2022 - 05/2014
2	Telangiectasis (Telangiectasia) 07/2014 - 05/2014
2	Adenocarcinoma of Lung 09/2013 - 08/2008
1	Mucopolysaccharidosis III (Sanfilippo Syndrome) 04/2024
1	Poisoning 03/2024
1	Autism Spectrum Disorder 02/2024
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Asthma (Bronchial Asthma) 12/2021
1	Gliosis 01/2020
1	Ischemia 01/2020
1	Radiation Injuries (Radiation Sickness) 07/2018
1	Colitis 03/2018

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2005
7	OrganophosphatesIBA 03/2024 - 01/2017
6	Isoflurophate (DFP)FDA Link 03/2024 - 01/2017
4	Glucose (Dextrose)FDA LinkGeneric 07/2023 - 06/2011
4	Biomarkers (Surrogate Marker)IBA 11/2020 - 10/2009
3	Eosine Yellowish-(YS) (Eosin)IBA 01/2019 - 05/2014
3	Hematoxylin (Haematoxylon)IBA 01/2019 - 05/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 05/2014
3	LigandsIBA 01/2013 - 12/2004
2	Nerve AgentsIBA 03/2024 - 01/2017
2	Midazolam (Versed)FDA LinkGeneric 03/2024 - 12/2021
2	Oxytocin (Pitocin)FDA LinkGeneric 02/2024 - 01/2020
2	MethyltransferasesIBA 11/2023 - 02/2023
2	DeuteriumIBA 07/2023 - 01/2022
2	Complement System Proteins (Complement)IBA 01/2022 - 01/2016
2	CytokinesIBA 01/2019 - 01/2018
2	Amino Acids FDA Link 07/2018 - 07/2013
2	Chemokine ReceptorsIBA 01/2018 - 12/2004
2	plerixafor FDA Link 01/2018 - 12/2004
2	AntibodiesIBA 01/2017 - 05/2014
2	Oxygen (Dioxygen)IBA 01/2016 - 01/2015
2	Bevacizumab (Avastin)FDA Link 11/2015 - 05/2014
2	Peptides (Polypeptides)IBA 05/2009 - 10/2003
2	CarcinogensIBA 03/2008 - 04/2004
2	ManganeseIBA 03/2008 - 05/2007
1	Diazepam (Valium)FDA LinkGeneric 03/2024
1	BenzodiazepinesIBA 03/2024
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 03/2024
1	Cholinergic Agents (Cholinergics)IBA 03/2024
1	DNA Methyltransferase 3AIBA 11/2023
1	A-Form DNA (A-DNA)IBA 11/2023
1	DNA (Deoxyribonucleic Acid)IBA 02/2023
1	Aquaporins (Water Channels)IBA 01/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	Amyloid beta-PeptidesIBA 01/2022
1	HydrogenIBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	Aquaporin 4IBA 01/2022
1	MitogensIBA 12/2021
1	DecorinIBA 12/2021
1	OvalbuminIBA 12/2021
1	tetramethylenedisulfotetramine (DSTA)IBA 12/2021
1	talazoparibIBA 05/2021
1	TritiumIBA 11/2020
1	Purine NucleosidesIBA 11/2020
1	Nudix HydrolasesIBA 11/2020
1	Connexin 43 (Connexin43)IBA 01/2020
1	beta-lapachoneIBA 01/2020
1	copper (II) diacetyl- di(N(4)- methylthiosemicarbazone)IBA 01/2020
1	NADP (NADPH)IBA 01/2020
1	2- (6- chloro- 2- (4- (3- fluoropropoxy)phenyl)imidazo(1,2- a)pyridin- 3- yl)- N,N- diethylacetamideIBA 01/2019
1	Proteasome InhibitorsIBA 01/2019
1	Bortezomib (Velcade)FDA Link 01/2019
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 07/2018
1	PolymersIBA 03/2018
1	Dextrans (Dextran)FDA Link 03/2018
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 03/2018

Therapy/Procedure

22	Therapeutics 03/2024 - 01/2002
7	Radiotherapy 10/2022 - 10/2015
5	Drug Therapy (Chemotherapy) 01/2021 - 02/2007
3	Chemoprevention 10/2009 - 08/2008
2	Cranial Irradiation 10/2015 - 10/2009
2	Lung Transplantation 01/2009 - 12/2007
1	Enzyme Replacement Therapy 04/2024
1	Induced Labor 02/2024
1	Immunotherapy 01/2021
1	Aftercare (After-Treatment) 01/2020
1	Extracorporeal Membrane Oxygenation 06/2018